{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:29:12Z","timestamp":1778603352433,"version":"3.51.4"},"reference-count":29,"publisher":"Frontiers Media SA","issue":"1","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1111\/tri.12878","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T13:43:40Z","timestamp":1476798220000},"page":"83-95","source":"Crossref","is-referenced-by-count":20,"title":["ADHERE: randomized controlled trial comparing renal function in<i>de novo<\/i>kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus"],"prefix":"10.3389","volume":"30","author":[{"given":"Oleg O.","family":"Rummo","sequence":"first","affiliation":[{"name":"Republican Scientific and Practical Center (RSPC) for Organ and Tissue Transplantation; Minsk Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Carmellini","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Neuroscience; Policlinico Santa Maria alle Scotte; University of Siena; Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Organ Transplantation; Toulouse University Hospital; INSERM U563, IFR-BMT, CHU Purpan; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Oberbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Nephrology and Dialysis; Medical University of Vienna; Vienna Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten H. L.","family":"Christiaans","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Division of Nephrology; Maastricht University Medical Center; Maastricht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Mousson","sequence":"additional","affiliation":[{"name":"Department of Nephrology-Transplantation; University Hospital; Dijon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Langer","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Surgery; Semmelweis University; Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Citterio","sequence":"additional","affiliation":[{"name":"Department of Surgery, Renal Transplantation; Catholic University; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Charpentier","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Transplantation; University Hospital of Bic\u00eatre; Le Kremlin Bicetre France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Brown","sequence":"additional","affiliation":[{"name":"Medical Affairs - Global; Astellas Pharma; Northbrook IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gbenga","family":"Kazeem","sequence":"additional","affiliation":[{"name":"Astellas Pharma Europe Ltd; Chertsey UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lehner","sequence":"additional","affiliation":[{"name":"General, Visceral and Transplantation Surgery; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the ADHERE study investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"10.1111\/tri.12878-BIB0001|tri12878-cit-0001","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5500\/wjt.v3.i4.68","article-title":"Novel immunosuppressive agents in kidney transplantation","volume":"3","author":"Hardinger","year":"2013","journal-title":"World J Transplant"},{"key":"10.1111\/tri.12878-BIB0002|tri12878-cit-0002","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0041-1345(02)02942-1","article-title":"Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study","volume":"34","author":"Mayer","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12878-BIB0003|tri12878-cit-0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/TP.0b013e3182708ea8","article-title":"Kidney graft survival in Europe and the United States: strikingly different long-term outcomes","volume":"95","author":"Gondos","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0004|tri12878-cit-0004","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1681\/ASN.2005050463","article-title":"Chronic renal allograft dysfunction","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12878-BIB0005|tri12878-cit-0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12878-BIB0006|tri12878-cit-0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14656566.2014.896900","article-title":"How to improve the survival of the kidney transplant - is it only the pharmaceutical management?","volume":"15","author":"Spasovski","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/tri.12878-BIB0007|tri12878-cit-0007","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/ndt\/gfq096","article-title":"High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation","volume":"25","author":"Borra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12878-BIB0008|tri12878-cit-0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2012.04281.x","article-title":"Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation","volume":"13","author":"Isakova","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12878-BIB0009|tri12878-cit-0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12878-BIB0010|tri12878-cit-0010","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12878-BIB0011|tri12878-cit-0011","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0012|tri12878-cit-0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2014.05.002","article-title":"Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes","volume":"31","author":"Shihab","year":"2014","journal-title":"Transpl Immunol"},{"key":"10.1111\/tri.12878-BIB0013|tri12878-cit-0013","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3182a203bd","article-title":"OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation","volume":"96","author":"Albano","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0014|tri12878-cit-0014","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/01.TP.0000071301.86299.75","article-title":"A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients","volume":"75","author":"Hooff","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0015|tri12878-cit-0015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.tp.0000232688.76018.19","article-title":"High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation","volume":"82","author":"Gelens","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0016|tri12878-cit-0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-6143.2005.01193.x","article-title":"Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study","volume":"6","author":"Vitko","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12878-BIB0017|tri12878-cit-0017","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0018|tri12878-cit-0018","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/17425255.2012.719874","article-title":"An evaluation of sirolimus in renal transplantation","volume":"8","author":"Halleck","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/tri.12878-BIB0019|tri12878-cit-0019","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.2004.00116.x","article-title":"Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation","volume":"18","author":"Lo","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12878-BIB0020|tri12878-cit-0020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2215\/CJN.09030911","article-title":"Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant","volume":"7","author":"Gelens","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/tri.12878-BIB0021|tri12878-cit-0021","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12878-BIB0022|tri12878-cit-0022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0041-1345(03)00210-0","article-title":"Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients","volume":"35","author":"Russ","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl. 1","key":"10.1111\/tri.12878-BIB0023|tri12878-cit-0023","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc10-S011","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1111\/tri.12878-BIB0024|tri12878-cit-0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12878-BIB0025|tri12878-cit-0025","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.5301\/jn.5000308","article-title":"Glomerular filtration rate: utility for assessing long-term renal allograft outcomes in kidney allograft recipients","volume":"26","author":"Marc\u00e9n","year":"2013","journal-title":"J Nephrol"},{"key":"10.1111\/tri.12878-BIB0026|tri12878-cit-0026","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.transproceed.2013.03.025","article-title":"A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft","volume":"45","author":"Bechstein","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12878-BIB0027|tri12878-cit-0027","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/TP.0b013e3182301602","article-title":"Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas","volume":"92","author":"Buron","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12878-BIB0028|tri12878-cit-0028","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","article-title":"Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review","volume":"156","author":"Earley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/tri.12878-BIB0029|tri12878-cit-0029","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study","volume":"10","author":"Kr\u00e4mer","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12878","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12878\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T16:29:54Z","timestamp":1657470594000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12878","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}